NCT00834587View on ClinicalTrials.gov

5 mg Glipizide/500 mg Metformin Hydrochloride Tablets, Non-Fasting

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

June 30, 2004

Study Completion Date

June 30, 2004

Conditions
Healthy
Interventions
DRUG

5 mg/500 mg METAGLIP™ Tablets

1 x 5 mg/500 mg, single-dose non-fasting

DRUG

5 mg/500 mg Glipizide Metformin Hydrochloride Tablets

1 x 5 mg/500 mg, single-dose non-fasting

Trial Locations (2)

56721

PRACS Institute Ltd., East Grand Forks

58104

PRACS Institute, Ltd., Fargo

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00834587 - 5 mg Glipizide/500 mg Metformin Hydrochloride Tablets, Non-Fasting | Biotech Hunter | Biotech Hunter